About Biomatter
Biomatter is a company based in Vilnius (Lithuania) founded in 2018 by Donatas Repecka and Laurynas Karpus. Biomatter has raised $7.73 million across 2 funding rounds from investors including 70V, UVC Partners and Inventure VC. Biomatter offers products and services including Protein Architecture and Biotech Tools.
- Headquarter Vilnius, Lithuania
- Founders Donatas Repecka, Laurynas Karpus
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomatter Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.73 M (USD)
in 2 rounds
-
Latest Funding Round
$7.12 M (USD), Seed
Aug 05, 2024
-
Investors
70V
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomatter
Biomatter offers a comprehensive portfolio of products and services, including Protein Architecture and Biotech Tools.
Protein design and engineering services are provided for various applications
Tools and equipment related to protein work are supplied in the biotechnology sector
Funding Insights of Biomatter
Biomatter has successfully raised a total of $7.73M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $7.12 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biomatter
Biomatter has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include 70V, UVC Partners and Inventure VC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward enterprise software, mobility, and industrial technologies.
|
Locked | Locked | Locked | |
|
Investments in early-stage tech startups are made by Inventure.
|
Locked | Locked | Locked | |
|
Seed to growth VC firm funding companies in the Baltics
|
Locked | Locked | Locked |
Investor details for Biomatter
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomatter
Investment portfolio details for Biomatter
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biomatter
Detailed financials for Biomatter
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomatter Comparisons
Peer comparison for Biomatter
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomatter
Detailed competitors of Biomatter
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomatter
Complete news archive for Biomatter
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomatter
Biomatter was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Biomatter is headquartered in Vilnius, Lithuania.
Laurynas Karpus is the current CEO of Biomatter. They have also founded this company.
Biomatter is a funded company, having raised a total of $7.73M across 2 funding rounds to date.
Biomatter was founded in 2018 in Vilnius, Lithuania, as a provider of synthetic biology and AI-based tools for generative protein design. An Intelligent Architecture platform is utilized to enable sequence- and structure-based redesign of existing proteins. Operations focus on applications in therapeutics, agriculture, molecular biology tools, food, and beverages, supporting advancements in these sectors through precise protein engineering.
Biomatter offers Protein Architecture and Biotech Tools.
Biomatter has 4 investors. Key investors include 70V, UVC Partners, Inventure VC, and Practica Capital.